Masaya Matsubayashi

Masaya Matsubayashi

Auto-generated profile, based on publicly available information

Masaya Matsubayashi

Nara Medical University, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
HNHitoki Nanaura
Hitoki Nanaura
HKHonoka Kawamukai
Honoka Kawamukai
AFAyano Fujiwara
Ayano Fujiwara
TUTakeru Uehara
Takeru Uehara
YAYuichiro Aiba
Yuichiro Aiba
EMEiichiro Mori
Eiichiro Mori
Nuclear import receptors (NIRs) not only transport RNA-binding proteins (RBPs) but also modify phase transitions of RBPs by recognizing nuclear localization signals (NLSs). Toxic arginine-rich poly-dipeptides from C9orf72 interact with NIRs and cause nucleocytoplasmic transport deficit. However, the molecular basis for the toxicity of arginine-rich poly-dipeptides toward NIRs function as phase modifiers of RBPs remains unidentified. Here we show that arginine-rich poly-dipeptides impede the ability of NIRs to modify phase transitions of RBPs. Isothermal titration calorimetry and size-exclusion chromatography revealed that proline:arginine (PR) poly-dipeptides tightly bind karyopherin-β2 (Kapβ2) at 1:1 ratio. The nuclear magnetic resonances of Kapβ2 perturbed by PR poly-dipeptides partially overlapped with those perturbed by the designed NLS peptide, suggesting that PR poly-dipeptides target the NLS binding site of Kapβ2. The findings offer mechanistic insights into how phase transitions of RBPs are disabled in C9orf72-related neurodegeneration.

23 December 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MMMasaya Matsubayashi
Masaya Matsubayashi
YSYoshihiko M. Sakaguchi
Yoshihiko M. Sakaguchi
YSYoshiki Sahara
Yoshiki Sahara
HNHitoki Nanaura
Hitoki Nanaura
SKSotaro Kikuchi
Sotaro Kikuchi
EMEiichiro Mori
Eiichiro Mori
The excretion and reabsorption of uric acid both to and from urine are tightly regulated by uric acid transporters. Metabolic syndrome conditions, such as obesity, hypercholesterolemia, and insulin resistance, are believed to regulate the expression of uric acid transporters and decrease the excretion of uric acid. However, the mechanisms driving cholesterol impacts on uric acid transporters have been unknown. Here, we show that cholesterol metabolite 27‐hydroxycholesterol (27HC) upregulates the uric acid reabsorption transporter URAT1 encoded by SLC22A12 via estrogen receptors (ER). Transcriptional motif analysis showed that the SLC22A12 gene promoter has more estrogen response elements (EREs) than other uric acid reabsorption transporters such as SLC22A11 and SLC22A13 , and 27HC‐activated SLC22A12 gene promoter via ER through EREs. Furthermore, 27HC increased SLC22A12 gene expression in human kidney organoids. Our results suggest that in hypercholesterolemic conditions, elevated levels of 27HC derived from cholesterol induce URAT1/ SLC22A12 expression to increase uric acid reabsorption, and thereby, could increase serum uric acid levels.

1 September 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SISoichiro S. Ito
Soichiro S. Ito
YNYosuke Nakagawa
Yosuke Nakagawa
MMMasaya Matsubayashi
Masaya Matsubayashi
YSYoshihiko M. Sakaguchi
Yoshihiko M. Sakaguchi
SKShinko Kobashigawa
Shinko Kobashigawa
TKTadaaki Kirita
Tadaaki Kirita
The anticancer agent 5-fluorouracil (5-FU) is cytotoxic and often used to treat various cancers. 5-FU is thought to inhibit the enzyme thymidylate synthase, which plays a role in nucleotide synthesis and has been found to induce single- and double-strand DNA breaks. ATR Ser/Thr kinase (ATR) is a principal kinase in the DNA damage response and is activated in response to UV- and chemotherapeutic drug–induced DNA replication stress, but its role in cellular responses to 5-FU is unclear. In this study, we examined the effect of ATR inhibition on 5-FU sensitivity of mammalian cells. Using immunoblotting, we found that 5-FU treatment dose-dependently induced the phosphorylation of ATR at the autophosphorylation site Thr-1989 and thereby activated its kinase. Administration of 5-FU with a specific ATR inhibitor (ATRi) remarkably decreased cell survival, compared with 5-FU treatment combined with other major DNA repair kinases inhibitors. Of note, the ATR inhibition enhanced induction of DNA double-strand breaks and apoptosis in 5-FU–treated cells. Using gene expression analysis, we found that 5-FU induced the activation of the intra-S cell cycle checkpoint. Cells lacking the BRCA2 were sensitive to 5-FU in the presence of ATRi. Moreover, the ATR inhibition enhanced the efficacy of the 5-FU treatment, independently of the non-homologous end-joining and homologous recombination repair pathways. These findings suggest that ATR could be a potential therapeutic target in 5-FU–based chemotherapy.

1 November 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SOShota Ozawa
Shota Ozawa
MMMasaya Matsubayashi
Masaya Matsubayashi
HNHitoki Nanaura
Hitoki Nanaura
MYMotoko Yanagita
Motoko Yanagita
KMKiyoshi Mori
Kiyoshi Mori
TNTakahiko Nakagawa
Takahiko Nakagawa
Podocyte injury is a critical step toward the progression of renal disease and is often associated with a loss of slit diaphragm (SD) proteins, including Podocin. While there is a possibility that the extracellular domain of these SD proteins can be a target for a pathological proteolysis, the precise mechanism driving the phenomenon remains unknown. Here we show that Matriptase, a membrane-anchored protein, was activated at podocytes in CKD patients and mice, while Matriptase inhibitors slowed the progression of mouse kidney disease. The mechanism could be accounted for by an imbalance favoring Matriptase over its cognate inhibitor, hepatocyte growth factor activator inhibitor type 1 (HAI-1), as conditional depletion of HAI-1 in podocytes accelerated podocyte injury in mouse model. Matriptase was capable of cleaving Podocin, but such a reaction was blocked by either HAI-1 or dominant negative Matriptase. Furthermore, the N-terminal of Podocin (Podocin-N), as a consequence of Matriptase cleavage of Podocin, translocated to nucleoli, suggesting that Podocin-N might be involved in the process of podocyte injury. Given these observations, we propose that the proteolytic cleavage of Podocin by Matriptase could potentially cause podocyte injury, and that targeting Matriptase could be a novel therapeutic strategy for CKD patients.

10 September 2017 in International Journal of Hyperthermia
Verified
Journal Article
Open access
YNYosuke Nakagawa
Yosuke Nakagawa
AKAtsuhisa Kajihara
Atsuhisa Kajihara
Akihisa TakahashiAkihisa Takahashi
Akihisa Takahashi
AMAkiho S. Murata
Akiho S. Murata
MMMasaya Matsubayashi
Masaya Matsubayashi
EMEiichiro Mori
Eiichiro Mori
Heat shock induces DNA double-strand breaks (DSBs) in mammalian cells. Mammalian cells are capable of repairing DSBs by utilising the homologous recombination (HR) pathway. Breast cancer susceptibility gene 2 (BRCA2) is known to regulate the HR pathway. Here, we investigate the role of BRCA2 in repairing DNA damage induced by heat shock. Chinese hamster lung fibroblast cell lines and human tongue squamous cell carcinoma SAS cells were used. RAD51 foci formation assay was used as an HR indicator. Heat sensitivity was analysed with colony forming assays. Phosphorylated histone H2AX (γH2AX) intensity, which correlates with the number of DSBs, was analysed with flow cytometry. RAD51 foci appeared with heat shock, and the number of cells with RAD51 foci was maximal at about 4 h after heat shock. Heat-induced RAD51 foci co-localised with γH2AX foci. BRCA2-deficient cells were sensitive to heat when compared to their parental wild-type cells. Heat-induced γH2AX was higher in BRCA2-deficient cells compared to parental cells. In SAS cells, cells transfected with BRCA2-siRNA were more sensitive to heat than cells transfected with negative control siRNA. Apoptotic bodies increased in number more rapidly in BRCA2-siRNA transfected cells than in cells transfected with negative control siRNA when cells were observed at 48 h after a heat treatment. In addition, cells deficient in BRCA2 were incapable of activating heat-induced G2/M arrest. BRCA2 has a protecting role against heat-induced cell death. BRCA2 might be a potential molecular target for hyperthermic cancer therapy.

4 November 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
NENobuyuki Eura
Nobuyuki Eura
TMTakeshi K. Matsui
Takeshi K. Matsui
JLJoachim Luginbühl
Joachim Luginbühl
MMMasaya Matsubayashi
Masaya Matsubayashi
HNHitoki Nanaura
Hitoki Nanaura
EMEiichiro Mori
Eiichiro Mori
Summary: The brainstem controls heartbeat, blood pressure and respiration, which are life-sustaining functions, therefore, disorders of the brainstem can be lethal. Brain organoids derived from human pluripotent stem cells recapitulate the course of human brain development and are expected to be useful for medical research on central nervous system disorders. However, existing organoid models have limitations, hampering the elucidation of diseases affecting specific components of the brain. Here, we developed a method to generate human brainstem organoids (hBSOs), containing neural crest stem cells as well as midbrain/hindbrain progenitors, noradrenergic and cholinergic neurons, and dopaminergic neurons, demonstrated by specific electrophysiological signatures. Single-cell RNA sequence analysis, together with proteomics and electrophysiology, revealed that the cellular population in these organoids was similar to that of the human brainstem and neural crest, which raises the possibility of making use of hBSOs in grafting for transplantation, efficient drug screenings and modeling the neural crest diseases.